{
  "id": 20569502,
  "title": "General : SELLAS Reports Positive Phase 3 Cancer Vaccine Trial Results",
  "url": "https://urgent.news/2026/11/18/general-sellas-reports-positive-phase-3-cancer-vaccine-trial-results",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-18T06:45:51.000Z",
  "source": {
    "name": "Bernama",
    "slug": "bernama",
    "url": "http://www.bernama.com/en/news.php?id=2636156"
  },
  "original_language": "en",
  "account": null,
  "summary": "KUALA LUMPUR, Nov 18 (Bernama) -- SELLAS Life Sciences Group Inc (SELLAS), a late-stage clinical biopharmaceutical company, has announced positive topline results from the pivotal randomised Phase 3 REGAL trial evaluating galinpepimut-S (GPS), an immunotherapeutic cancer vaccine, in patients with acute myeloid leukaemia (AML).",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}